InMed Pharmaceuticals Inc (INM)

[Aliquot]

I believe we are moving towards a paradigm where individual genetics and physiology will be matched by computer algorithms to to chemotype profiles of different strains. Sure you can make a drug that will treat 30% of people successfully, but if those people had the opportunity to try a few differ net chemo types you might treat 50% successfully. And those same oils could be used to treat a whole bunch of other ailments.

We are a long way from there, but it is coming.

Next is the yeast thing. Cannabis plants make hundreds of active compounds. Purified cannabinoids don't work as well as whole plant extracts. The whole is the sum of its parts.

This company may be successful but it's a long way off in a very narrow business plan.